|
1
|
Bishop JO and Madson EC: Retinoblastoma.
Review of the current status. Surv Ophthalmol. 19:342–366.
1975.PubMed/NCBI
|
|
2
|
Knudson AG: Cancer genetics. Am J Med
Genet. 111:96–102. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Corson TW and Gallie BL: One hit, two
hits, three hits, more? Genomic changes in the development of
retinoblastoma. Genes Chromosomes Cancer. 46:617–634. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vandhana S, Lakshmi TS, Indra D, Deepa PR
and Krishnakumar S: Microarray analysis and biochemical
correlations of oxidative stress responsive genes in
retinoblastoma. Curr Eye Res. 37:830–841. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tannu NS and Hemby SE: Methods for
proteomics in neuroscience. Prog Brain Res. 158:41–82. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shields CL, Mashayekhi A, Au AK, Czyz C,
Leahey A, Meadows AT and Shields JA: The International
Classification of Retinoblastoma predicts chemoreduction success.
Ophthalmology. 113:2276–2280. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Munier FL, Soliman S, Moulin AP, Gaillard
MC, Balmer A and Beck-Popovic M: Profiling safety of intravitreal
injections for retinoblastoma using an anti-reflux procedure and
sterilisation of the needle track. Br J Ophthalmol. 96:1084–1087.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Duan X, Lu Q, Xue P, Zhang H, Dong Z, Yang
F and Wang N: Proteomic analysis of aqueous humor from patients
with myopia. Mol Vis. 14:370–377. 2008.PubMed/NCBI
|
|
9
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Steele FR, Chader GJ, Johnson LV and
Tombran-Tink J: Pigment epithelium-derived factor: Neurotrophic
activity and identification as a member of the serine protease
inhibitor gene family. Proc Natl Acad Sci USA. 90:pp. 1526–1530.
1993, View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dawson DW, Volpert OV, Gillis P, Crawford
SE, Xu H, Benedict W and Bouck NP: Pigment epithelium-derived
factor: A potent inhibitor of angiogenesis. Science. 285:245–248.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Subramanian P, Deshpande M,
Locatelli-Hoops S, Moghaddam-Taaheri S, Gutierrez D, Fitzgerald DP,
Guerrier S, Rapp M, Notario V and Becerra SP: Identification of
pigment epithelium-derived factor protein forms with distinct
activities on tumor cell lines. J Biomed Biotechnol.
2012:4259072012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guan M, Jiang H, Xu C, Xu R, Chen Z and Lu
Y: Adenovirus-mediated PEDF expression inhibits prostate cancer
cell growth and results in augmented expression of PAI-2. Cancer
Biol Ther. 6:419–425. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guan M, Pang CP, Yam HF, Cheung KF, Liu WW
and Lu Y: Inhibition of glioma invasion by overexpression of
pigment epithelium-derived factor. Cancer Gene Ther. 11:325–332.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Orgaz JL, Ladhani O, Hoek KS,
Fernández-Barral A, Mihic D, Aguilera O, Seftor EA, Bernad A,
Rodríguez-Peralto JL, Hendrix MJ, et al: ‘Loss of pigment
epithelium-derived factor enables migration, invasion and
metastatic spread of human melanoma’. Oncogene. 28:4147–4161. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li L, Yao YC, Fang SH, Ma CQ, Cen Y, Xu
ZM, Dai ZY, Li C, Li S, Zhang T, et al: Pigment epithelial-derived
factor (PEDF)-triggered lung cancer cell apoptosis relies on p53
protein-driven Fas ligand (Fas-L) up-regulation and Fas protein
cell surface translocation. J Biol Chem. 289:30785–30799. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bouck N: PEDF: Anti-angiogenic guardian of
ocular function. Trends Mol Med. 8:330–334. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mori K, Duh E, Gehlbach P, Ando A,
Takahashi K, Pearlman J, Mori K, Yang HS, Zack DJ, Ettyreddy D, et
al: Pigment epithelium-derived factor inhibits retinal and
choroidal neovascularization. J Cell Physiol. 188:253–263. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Amaral J and Becerra SP: Effects of human
recombinant PEDF protein and PEDF-derived peptide 34-mer on
choroidal neovascularization. Invest Ophthalmol Vis Sci.
51:1318–1326. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang H, Cheng R, Liu G, Zhong Q, Li C, Cai
W, Yang Z, Ma J, Yang X and Gao G: PEDF inhibits growth of
retinoblastoma by anti-angiogenic activity. Cancer Sci.
100:2419–2425. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chazaud C, Bouillet P, Oulad-Abdelghani M
and Dollé P: Restricted expression of a novel retinoic acid
responsive gene during limb bud dorsoventral patterning and
endochondral ossification. Dev Genet. 19:66–73. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kawaguchi R, Yu J, Honda J, Hu J,
Whitelegge J, Ping P, Wiita P, Bok D and Sun H: A membrane receptor
for retinol binding protein mediates cellular uptake of vitamin A.
Science. 315:820–825. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Berry DC, Levi L and Noy N:
Holo-retinol-binding protein and its receptor STRA6 drive oncogenic
transformation. Cancer Res. 74:6341–6351. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Szeto W, Jiang W, Tice DA, Rubinfeld B,
Hollingshead PG, Fong SE, Dugger DL, Pham T, Yansura DG, Wong TA,
et al: Overexpression of the retinoic acid-responsive gene Stra6 in
human cancers and its synergistic induction by Wnt-1 and retinoic
acid. Cancer Res. 61:4197–4205. 2001.PubMed/NCBI
|
|
25
|
Carrera S, Cuadrado-Castano S, Samuel J,
Jones GD, Villar E, Lee SW and Macip S: Stra6, a retinoic
acid-responsive gene, participates in p53-induced apoptosis after
DNA damage. Cell Death Differ. 20:910–919. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dube DH and Bertozzi CR: Glycans in cancer
and inflammation-potential for therapeutics and diagnostics. Nat
Rev Drug Discov. 4:477–488. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bertozzi CR and Kiessling LL: Chemical
glycobiology. Science. 291:2357–2364. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen S, LaRoche T, Hamelinck D, Bergsma D,
Brenner D, Simeone D, Brand RE and Haab BB: Multiplexed analysis of
glycan variation on native proteins captured by antibody
microarrays. Nat Methods. 4:437–444. 2007.PubMed/NCBI
|
|
29
|
Taniguchi N and Kizuka Y: Glycans and
cancer: Role of N-glycans in cancer biomarker, progression and
metastasis, and therapeutics. Adv Cancer Res. 126:11–51. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pinho SS and Reis CA: Glycosylation in
cancer: Mechanisms and clinical implications. Nat Rev Cancer.
15:540–555. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Compagno D, Gentilini LD, Jaworski FM,
Pérez IG, Contrufo G and Laderach DJ: Glycans and galectins in
prostate cancer biology, angiogenesis and metastasis. Glycobiology.
24:899–906. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kreunin P, Zhao J, Rosser C, Urquidi V,
Lubman DM and Goodison S: Bladder cancer associated glycoprotein
signatures revealed by urinary proteomic profiling. J Proteome Res.
6:2631–2639. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tian M, Cui YZ, Song GH, Zong MJ, Zhou XY,
Chen Y and Han JX: Proteomic analysis identifies MMP-9, DJ-1 and
A1BG as overexpressed proteins in pancreatic juice from pancreatic
ductal adenocarcinoma patients. BMC cancer. 8:2412008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Libreros S and Iragavarapu-Charyulu V:
YKL-40/CHI3L1 drives inflammation on the road of tumor progression.
J Leukoc Biol. 98:931–936. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang XW, Cai CL, Xu JM, Jin H and Xu ZY:
Increased expression of chitinase 3-like 1 is a prognosis marker
for non-small cell lung cancer correlated with tumor angiogenesis.
Tumour Biol. 36:901–907. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kushner I: Regulation of the acute phase
response by cytokines. Perspect Biol Med. 36:611–622. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Davalieva K, Kiprijanovska S, Komina S,
Petrusevska G, Zografska NC and Polenakovic M: Proteomics analysis
of urine reveals acute phase response proteins as candidate
diagnostic biomarkers for prostate cancer. Proteome Sci. 13:22015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hoenerhoff MJ: Inflammation and cancer:
Partners in crime. Vet J. 206:1–2. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Raposo TP, Beirão BC, Pang LY, Queiroga FL
and Argyle DJ: Inflammation and cancer: Till death tears them
apart. Vet J. 205:161–174. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gerner C, Steinkellner W, Holzmann K, Gsur
A, Grimm R, Ensinger C, Obrist P and Sauermann G: Elevated plasma
levels of crosslinked fibrinogen gamma-chain dimer indicate
cancer-related fibrin deposition and fibrinolysis. Thromb Haemost.
85:494–501. 2001.PubMed/NCBI
|
|
41
|
Palumbo JS, Talmage KE, Massari JV, La
Jeunesse CM, Flick MJ, Kombrinck KW, Jirousková M and Degen JL:
Platelets and fibrin(ogen) increase metastatic potential by
impeding natural killer cell-mediated elimination of tumor cells.
Blood. 105:178–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bloomston M, Zhou JX, Rosemurgy AS,
Frankel W, Muro-Cacho CA and Yeatman TJ: Fibrinogen gamma
overexpression in pancreatic cancer identified by large-scale
proteomic analysis of serum samples. Cancer Res. 66:2592–2599.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang J, Xiong X, Wang X, Guo B, He K and
Huang C: Identification of peptide regions of SERPINA1 and ENOSF1
and their protein expression as potential serum biomarkers for
gastric cancer. Tumour Biol. 36:5109–5118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kwon CH, Park HJ, Choi JH, Lee JR, Kim HK,
Jo HJ, Kim HS, Oh N, Song GA and Park DY: Snail and serpinA1
promote tumor progression and predict prognosis in colorectal
cancer. Oncotarget. 6:20312–20326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kwon CH, Park HJ, Lee JR, Kim HK, Jeon TY,
Jo HJ, Kim DH, Kim GH and Park DY: Serpin peptidase inhibitor clade
A member 1 is a biomarker of poor prognosis in gastric cancer. Br J
Cancer. 111:1993–2002. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang X, Xiao Z, Liu X, Du L, Wang L, Wang
S, Zheng N, Zheng G, Li W, Zhang X, et al: The potential role of
ORM2 in the development of colorectal cancer. PLoS One.
7:e318682012. View Article : Google Scholar : PubMed/NCBI
|
